Request Appointment
161 Fort Washington AvenueNew York, NY 10032
Overview of Dr. Trivedi
Dr. Meghna Trivedi is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from University of Maryland School of Medicine and has been in practice 7 years. She is one of 369 doctors at New York-Presbyterian Hospital and one of 121 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. She has more than 30 publications and over 500 citings.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 2013 - 2016
University of Pennsylvania Health SystemResidency, Internal Medicine, 2010 - 2013
University of Maryland School of MedicineClass of 2010
Certifications & Licensure
NY State Medical License 2013 - 2026
PA State Medical License 2010 - 2013
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Use of a Smartphone Application to Promote Adherence to Oral Medications in Patients With Breast Cancer.Claire Sathe, Rohit Raghunathan, Sophie Ulene, Fiona McAuley, Kishan A Bhatt
JCO Oncology Practice. 2025-02-01 - 4 citationsDatopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Katia Khoury, Jane L Meisel, Christina Yau, Hope S Rugo, Rita Nanda
Nature Medicine. 2024-12-01 - 10 citationsDatopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial.Rebecca A Shatsky, Meghna S Trivedi, Christina Yau, Rita Nanda, Hope S Rugo
Nature Medicine. 2024-12-01
Press Mentions
I-sPY2.2: Dato-DXd plus Durvalumab Yields High Pathologic Response Rate in Breast Cancer SubsetOctober 23rd, 2024- Breast Cancer: What to Know About Genetic TestingOctober 16th, 2024
- Cancer Prevention Strategies Linked to Mortality Reduction in BRCA CarriersMarch 6th, 2024
- Join now to see all
Grant Support
- Development of an Integrated Risk Prediction Model of Taxane-induced Peripheral NeuropathyUNIVERSITY OF MICHIGAN AT ANN ARBOR2023–2027
- Development of an Integrated Risk Prediction Model of Taxane-induced Peripheral NeuropathyUNIVERSITY OF MICHIGAN AT ANN ARBOR2023–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
